Unacceptable Principal Diagnosis Codes

Underdosing of other antipsychotics and neuroleptics, initial encounter

Underdosing of other antipsychotics and neuroleptics, subsequent encounter

Underdosing of other antipsychotics and neuroleptics, sequela

Adverse effect of unspecified psychostimulants, initial encounter

Adverse effect of unspecified psychostimulants, subsequent encounter

Adverse effect of unspecified psychostimulants, sequela

Underdosing of unspecified psychostimulants, initial encounter

Underdosing of unspecified psychostimulants, subsequent encounter

Underdosing of unspecified psychostimulants, sequela

Adverse effect of caffeine, initial encounter

Adverse effect of caffeine, subsequent encounter

Adverse effect of caffeine, sequela

Underdosing of caffeine, initial encounter

Underdosing of caffeine, subsequent encounter

Underdosing of caffeine, sequela

Adverse effect of amphetamines, initial encounter

Adverse effect of amphetamines, subsequent encounter

Adverse effect of amphetamines, sequela

Underdosing of amphetamines, initial encounter

Underdosing of amphetamines, subsequent encounter

Underdosing of amphetamines, sequela

Adverse effect of methylphenidate, initial encounter

Adverse effect of methylphenidate, subsequent encounter

Adverse effect of methylphenidate, sequela

Underdosing of methylphenidate, initial encounter

Underdosing of methylphenidate, subsequent encounter

Underdosing of methylphenidate, sequela

Adverse effect of methamphetamines, initial encounter

Adverse effect of methamphetamines, subsequent encounter

Adverse effect of methamphetamines, sequela

Underdosing of methamphetamines, initial encounter

Underdosing of methamphetamines, subsequent encounter

Underdosing of methamphetamines, sequela

Adverse effect of other psychostimulants, initial encounter

Adverse effect of other psychostimulants, subsequent encounter

Adverse effect of other psychostimulants, sequela

Underdosing of other psychostimulants, initial encounter

Underdosing of other psychostimulants, subsequent encounter

Underdosing of other psychostimulants, sequela

Adverse effect of other psychotropic drugs, initial encounter

Adverse effect of other psychotropic drugs, subsequent encounter

Adverse effect of other psychotropic drugs, sequela

Underdosing of other psychotropic drugs, initial encounter

Underdosing of other psychotropic drugs, subsequent encounter

Underdosing of other psychotropic drugs, sequela

Adverse effect of unspecified psychotropic drug, initial encounter

Adverse effect of unspecified psychotropic drug, subsequent encounter

Adverse effect of unspecified psychotropic drug, sequela

Underdosing of unspecified psychotropic drug, initial encounter

Underdosing of unspecified psychotropic drug, subsequent encounter

Underdosing of unspecified psychotropic drug, sequela

Adverse effect of anticholinesterase agents, initial encounter

Adverse effect of anticholinesterase agents, subsequent encounter

Adverse effect of anticholinesterase agents, sequela

Underdosing of anticholinesterase agents, initial encounter

Underdosing of anticholinesterase agents, subsequent encounter

Underdosing of anticholinesterase agents, sequela

Adverse effect of other parasympathomimetics [cholinergics], initial encounter

Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter

Adverse effect of other parasympathomimetics [cholinergics], sequela

Underdosing of other parasympathomimetics [cholinergics], initial encounter

Underdosing of other parasympathomimetics [cholinergics], subsequent encounter

Underdosing of other parasympathomimetics [cholinergics], sequela

Adverse effect of ganglionic blocking drugs, initial encounter

Adverse effect of ganglionic blocking drugs, subsequent encounter

Adverse effect of ganglionic blocking drugs, sequela

Underdosing of ganglionic blocking drugs, initial encounter

Underdosing of ganglionic blocking drugs, subsequent encounter

Underdosing of ganglionic blocking drugs, sequela

Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter

Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter

Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter

Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela

Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter

Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter

Underdosing of predominantly alpha-adrenoreceptor agonists, sequela

Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter

Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter

Adverse effect of predominantly beta-adrenoreceptor agonists, sequela

Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter

Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter

Underdosing of predominantly beta-adrenoreceptor agonists, sequela

Adverse effect of alpha-adrenoreceptor antagonists, initial encounter

Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter

Adverse effect of alpha-adrenoreceptor antagonists, sequela

Underdosing of alpha-adrenoreceptor antagonists, initial encounter

Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter

Underdosing of alpha-adrenoreceptor antagonists, sequela

Adverse effect of beta-adrenoreceptor antagonists, initial encounter

Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter

Adverse effect of beta-adrenoreceptor antagonists, sequela

Underdosing of beta-adrenoreceptor antagonists, initial encounter

Underdosing of beta-adrenoreceptor antagonists, subsequent encounter

Underdosing of beta-adrenoreceptor antagonists, sequela

Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter